Finance

Lists
Why is OTLK down 3,81%?
Dive Deeper
OTLK:NASDAQ
Outlook Therapeutics Inc
0,57 USD
-3,81%
(-0,023) 1D
6-окт., 13:39:19 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLK...
Open
0,60 USD
High
0,62 USD
Low
0,57 USD
Mkt. cap
137,82 млн
Avg. vol.
5,64 млн
Volume
2,28 млн
52-wk high
2,54 USD
52-wk low
0,16 USD
EPS
-0,87 USD
Beta
0,66
Shares outstanding
243,45 млн
No. of employees
17
Open
0,60 USD
High
0,62 USD
Low
0,57 USD
Mkt. cap
137,82 млн
Avg. vol.
5,64 млн
Volume
2,28 млн
52-wk high
2,54 USD
52-wk low
0,16 USD
EPS
-0,87 USD
Beta
0,66
Shares outstanding
243,45 млн
No. of employees
17
News stories
From web sources and news partners
About Outlook Therapeutics Inc
CEO-
Employees17
Founded2010
Headquarters-
Sector-
Websiteoutlooktherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to OTLK in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OTLK in the last 3 months.
Highest
Current 0,57 USD
10,50 USD (+1 733,10%)
Average
5,37 USD (+837,50%)
Lowest
1,60 USD (+179,33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
10,50 USD
+1 733,1%
09/10/2026
Julian Harrison
BTIG
Buy
Reiterated
4,00 USD
+598,3%
08/14/2026
Douglas Tsao
H.C. Wainwright
Hold
Reiterated
1,60 USD
+179,3%
07/28/2026
Daniil Gataulin
Chardan Capital
Hold
Maintained
1,00 USD
+74,6%
01/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-91,79 миң
-1,21 млн
127,44 миң
8,70 миң
Cost of goods sold
916,52 миң
29,63 миң
149,33 миң
16,96 миң
Cost of revenue
916,52 миң
29,63 миң
149,33 миң
16,96 миң
Research and development expenses
5,98 млн
3,63 млн
4,50 млн
3,25 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,33 млн
8,61 млн
9,50 млн
7,55 млн
Operating expense
16,31 млн
12,25 млн
14,01 млн
10,80 млн
Total operating expenses
17,22 млн
12,28 млн
14,15 млн
10,82 млн
Operating income
-17,31 млн
-13,48 млн
-14,03 млн
-10,81 млн
Other non operating income
3,02 млн
-2,79 млн
6,84 млн
-7,04 млн
EBT including unusual items
-14,85 млн
-23,06 млн
-4,45 млн
-20,32 млн
EBT excluding unusual items
-14,51 млн
-16,31 млн
-7,23 млн
-17,89 млн
Income tax expense
-1,55 млн
-
-
-
Effective tax rate
10,47%
-
-
-
Other operating expenses
-
-
-
-
Net income
-13,29 млн
-23,06 млн
-4,45 млн
-20,32 млн
Net profit margin
14 482,19%
1 909,05%
-3 494,28%
-233 554,85%
Earnings per share
-0,29
-0,22
-0,17
-0,09
Interest and investment income
89,74 миң
-
3,00
7,00
Interest expense
-264,16 миң
-
-
-
Net interest expenses
-174,42 миң
-
3,00
7,00
Depreciation and amortization charges
-
-
-
-
EBITDA
-17,28 млн
-13,45 млн
-14,00 млн
-10,80 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору